Bruker showcases high-performance solutions at Analytica 2024 for research and analysis in applied, industrial and biopharma laboratories Post author: Post published:April 9, 2024 Post category:uncategorized Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024: You Might Also Like Understanding the age gap in leukemia survival rates August 7, 2024 MaxCyte joins the alliance for mRNA medicines (AMM) as a founding member November 22, 2023 How your skin’s microbes shape immunity, inflammation, and chronic skin disease April 2, 2025